期刊文献+
共找到307篇文章
< 1 2 16 >
每页显示 20 50 100
Effects of genistein and equol on human and rat testicular 3β-hydroxysteroid dehydrogenase and 17β-hydroxysteroid dehydrogenase 3 activities 被引量:6
1
作者 Guo-Xin Hu Bing-Hai Zhao +4 位作者 Yan-Hui Chu Hong-Yu Zhou Benson T. Akingbemi Zhi-Qiang Zheng Ren-Shan Ge 《Asian Journal of Andrology》 SCIE CAS CSCD 2010年第4期519-526,共8页
The objective of the present study was to investigate the effects of genistein and equol on 3β-hydroxysteroid de- hydrogenase (3β-HSD) and 17β-hydroxysteroid dehydrogenase 3 (17β-HSD3) in human and rat testis ... The objective of the present study was to investigate the effects of genistein and equol on 3β-hydroxysteroid de- hydrogenase (3β-HSD) and 17β-hydroxysteroid dehydrogenase 3 (17β-HSD3) in human and rat testis microsomes. These enzymes (3β-HSD and 17β-HSD3), along with two others (cytochrome P450 side-chain cleavage enzyme and cytochrome P450 17α-hydroxylase/17-20 lyase), catalyze the reactions that convert the steroid cholesterol into the sex hormone testosterone. Genistein inhibited 3β-HSD activity (0.2 μmol L^-1 pregnenolone) with half-maximal inhibition or a half-maximal inhibitory concentration (IC50) of 87 ± 15 (human) and 636 ± 155 nmol L^-1 (rat). Genistein's mode of action on 3β-HSD activity was competitive for the substrate pregnenolonrge and noncompetitive for the cofactor NAD+. There was no difference in genistein's potency of 3β-HSD inhibition between intact rat Leydig cells and testis microsomes. In contrast to its potent inhibition of 3β-HSD, genistein had lesser effects on human and rat 17β-HSD3 (0.1 μmol L^-1 androstenedione), with an IC50 〉 100μmol L^-1. On the other hand, equol only inhibited human 3β-HSD by 42%, and had no effect on 3β-HSD and 17β-HSD3 in rat tissues. These observations imply that the ability of soy isoflavones to regulate androgen biosynthesis in Leydig cells is due in part to action on Leydig cell 3β- HSD activity. Given the increasing intake of soy-based food products and their potential effect on blood androgen levels, these findings are greatly relevant to public health. 展开更多
关键词 3β-hydroxysteroid dehydrogenase 17β-hydroxysteroid dehydrogenase 3 enzyme inhibition EQUOL GENISTEIN
在线阅读 下载PDF
11β-hydroxysteroid dehydrogenase types 1 and 2. in postnatal development of rat testis: gene express,on, localization and regulation by luteinizing hormone and androgens 被引量:1
2
作者 Hong-Yu Zhou Xin-Xin Chen +2 位作者 Han Lin Ai-Li Fei Ren-Shan Ge 《Asian Journal of Andrology》 SCIE CAS CSCD 2014年第6期811-816,共6页
11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) and type 2 (11β-HSD2) are expressed in rat testis, where they regulate the local concentrations of glucocorticoids. Here, we investigated the expression and lo... 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) and type 2 (11β-HSD2) are expressed in rat testis, where they regulate the local concentrations of glucocorticoids. Here, we investigated the expression and localization of 11β-HSD in rat testis during postnatal development, and the regulation of these genes by luteinizing hormone (LH) and androgens, mRNA and protein levels were analyzed by quantitative real-time-polymerase chain reaction and western blotting, respectively, in testes collected from rats at postnatal day (PND) 7, 14, 21, 35, and 90, and from rats treated with LH, 7α.methyl-19-nortestosterone (MENT) and testosterone at PND 21 and PND 90. Immunohistochemical staining was used to identify the localization of the 11β-HSD in rat testis at PND 7, 14, and 90. We found that 11β-HSD1 expression was restricted to the interstitial areas, and that its levels increased during rat testis development. In contrast, whereas 11β-HSD2 was expressed in both the interstitial areas and seminiferous tubules at PND 7, it was present only in the interstitial areas at PND 90, and its levels declined during testicular development. Moreover, 11β-HSD1 mRNA was induced by LH in both the PND 21 and 90 testes and by MENT at PND 21, whereas 11β-HSD2 mRNA was induced by testosterone and MENT in the PND 21 testis and by LH in the PND 90 testis. In conclusion, our study indicates that the 11β-HSD1 and 11β-HSD2 genes have distinct patterns of spatiotemporal expression and hormonal regulation during postnatal development of the rat testis. 展开更多
关键词 11β-hydroxysteroid dehydrogenase type 1 11β-hydroxysteroid dehydrogenase type 2 development Leydig cell TESTIS
在线阅读 下载PDF
Recombinant adenovirus-mediated overexpression of 3β-hydroxysteroid-Δ24 reductase 被引量:1
3
作者 Xiuli Lu Dan Jia +6 位作者 Chenguang Zhao Weiqi Wang Ting Liu Shuchao Chen Xiaoping Quan Deliang Sun Bing Gao 《Neural Regeneration Research》 SCIE CAS CSCD 2014年第5期504-512,共9页
3β-Hydroxysteroid-△24 reductase (DHCR24) is a multifunctional enzyme that localizes to the endoplasmic reticulum and has neuroprotective and cholesterol-synthesizing activities. DHCR24 overexpression confers neuro... 3β-Hydroxysteroid-△24 reductase (DHCR24) is a multifunctional enzyme that localizes to the endoplasmic reticulum and has neuroprotective and cholesterol-synthesizing activities. DHCR24 overexpression confers neuroprotection against apoptosis caused by amyloid β deposition. The present study aimed to construct two recombinant adenoviruses driving DHCR24 expression specifically in neurons. Two SYN1 promoter DNA fragments were obtained from human (h) and rat (r). Recombinant Ad-r(h)SYN1-DHCR24 was transfected into AD-293, N2A (mouse neuroblastoma), and MIN6 (mouse pancreatic carcinoma) cells. Western blot analysis showed DHCR24 was specially expressed in 293 and N2A cells, but no specific band was found in MIN6 cells. This demonstrates that the recombinant adenoviruses successfully express DHCR24, and no expression is observed in non-neuronal cells. TUNEL assay results showed apoptosis was inhibited in adenovirus-transfected neurons. Detecting reactive oxygen species by immunoflu- orescence, we found that adenovirus transfection inhibits apoptosis through scavenging excess reactive oxygen species. Our findings show that the recombinant DHCR24 adenoviruses induce neuron-specific DHCR24 expression, and thereby lay the foundation for further studies on DHCR24 gene therapy for Alzheimer's disease. 展开更多
关键词 nerve degeneration 3β-hydroxysteroid-△ 2 4 reductase recombinant adenovirus neuron oxidative stress synapsin-1 gene therapy NEUROPROTECTION NSFC grant neural regeneration
暂未订购
Increased Expression of 11<i>β</i>-Hydroxysteroid Dehydrogenase Type 1 in Experimental Periodontitis Induced by Lipopolysaccharide from <i>Porphyromonas gingivalis</i> 被引量:1
4
作者 Atsuko Fujita Takaya Nakata +2 位作者 Makoto Umeda Hiroaki Masuzaki Hirofumi Sawai 《Open Journal of Stomatology》 2017年第10期429-438,共10页
It has been proposed that 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), which activates glucocorticoids, plays a role in chronic inflammatory diseases including metabolic diseases, rheumatoid arthritis, and ul... It has been proposed that 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), which activates glucocorticoids, plays a role in chronic inflammatory diseases including metabolic diseases, rheumatoid arthritis, and ulcerative colitis. We have recently reported that the expression of 11β-HSD1 is increased in the gingiva of patients with chronic periodontitis and in that of rats with ligature-induced periodontitis. In this study, to further demonstrate the involvement of 11β-HSD1 in chronic periodontitis, the expression of 11β-HSD1 was investigated in another rat model of experimental periodontitis induced by intragingival injection of lipopolysaccharide from Porphyromonas gingivalis (LPS-PG). Alveolar bone loss was observed two weeks after intragingival injection of LPS-PG. The level of 11β-HSD1 mRNA assessed by real-time reverse transcriptase-polymerase chain reaction was significantly elevated in LPS-PG-induced periodontitis compared with controls. The expression of 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2), which inactivates glucocorticoids, was not significantly different between control and LPS-PG-induced periodontitis. The expression of 11β-HSD1 was significantly correlated with that of TNF in LPS-PG-induced periodontitis. The increased expression of 11β-HSD1 protein in LPS-PG-induced periodontitis was confirmed by immunohistochemistry using anti-11β-HSD1 antibody. These results further suggest a role for 11β-HSD1 in the pathogenesis of chronic periodontitis. 展开更多
关键词 Chronic PERIODONTITIS 11β-hydroxysteroid Dehydrogenase TYPE 1 LIPOPOLYSACCHARIDE PORPHYROMONAS gingivalis
暂未订购
Interceptive Activities of Some New 3β─Hydroxysteroid Dehydrogenase Inhibitors
5
作者 刘昌官 马如鸿 +1 位作者 王忠兴 林中明 《Journal of Reproduction and Contraception》 CAS 1995年第2期111-121,共11页
Fourteen compounds of azastene and epostane derivatives (from YG101 to YG114) have been studied. Results showed that only YG102 and YG103 wore found to be positive in interceptivo activities, although they were less p... Fourteen compounds of azastene and epostane derivatives (from YG101 to YG114) have been studied. Results showed that only YG102 and YG103 wore found to be positive in interceptivo activities, although they were less potent than their parent compound──azastene. Levels ofprogesterone in plasma were decreased significantly after administrstion or YG102, 103 and 106. Only YG107 possessed an interceptive activity approximately as potent as that of its paront compound──epostane. Epostane is a mixture of its enol and keto forms and the percentage of both forms defends on various condions. Since YG107 exists only in one form, we believe this derivative of epostane might be useful in the future work. 展开更多
关键词 Epostane Azastene 3β─hydroxysteroid DEHYDROGENASE Interceptive activities PROGESTERONE CORTICOSTERONE
暂未订购
Effect of glucocorticoid on promoter of 11β-hydroxysteroid dehydrogenase I gene
6
作者 何平 孙刚 《Journal of Medical Colleges of PLA(China)》 CAS 2003年第3期150-153,共4页
Objective: To study the effect of glucocorticoid on the promoter of the pre-receptor glucocorticoid metabolizing enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) gene. Methods: The 1. 2 kb length sequence u... Objective: To study the effect of glucocorticoid on the promoter of the pre-receptor glucocorticoid metabolizing enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) gene. Methods: The 1. 2 kb length sequence upstream to the transcription start site of the 11β-HSD1 gene was amplified with polymerase chain reaction (PCR) and then was cloned into pBLCAT6 plasmid carrying chloramphenicol acetyltransferase ( CAT) reporter gene. The plasmid pBLCAT6 carrying the promoter and reporter gene was used to transfect HeLa cells to study the regulation of 11β-HSD1 gene expression by glucocorticoids in terms of reporter gene expression. Results: PCR showed that there was a complete alignment of the amplified sequence with the sequence 1. 2 kb upstream to the transcription start site of 11β-HSD1 gene. When cloned into pBLCAT6 plasmid carrying the reporter gene, this part of the promoter is functional in terms of regulation of reporter gene expression upon transfection into HeLa cells. The synthetic glucocorticoid-dexamethasone induced the reporter gene expression in the system described above, which was blocked by glucocorticoid receptor antagonist RU486. Conclusion: Glucocorticoids can modulate the expression of 11β-HSD1 through a mechanism involving activation of GR and interaction of the promoter of 11β-HSD1 gene. 展开更多
关键词 11β- hydroxysteroid dehydrogenase PROMOTER GLUCOCORTICOID
暂未订购
Activity of Salivary 11<i>β</i>-Hydroxysteroid Dehydrogenase Type 2 Becomes the Index for the Continuous Strength Exercise to Prevent Locomotive Syndrome in Japan
7
作者 Noboru Hasegawa Maki Ohara Miyako Mochizuki 《Health》 2015年第10期1352-1356,共5页
The Japanese Orthopedic Association proposed a concept called locomotive syndrome (LS) to identify middle-aged and older adults at high risk of requiring health care services because of problems with locomotion-associ... The Japanese Orthopedic Association proposed a concept called locomotive syndrome (LS) to identify middle-aged and older adults at high risk of requiring health care services because of problems with locomotion-associated lower muscle mass. To prevent LS, it is important to increase muscle mass and muscle strength in middle-age by continuous resistance training. A total of 38 men and women were assessed at baseline and 6 months. Body composition, physical strength and salivary cortisol and cortisone were analyzed. The exercise intervention program was performed by individual muscle endurance level. Body weight, muscle weight and basal metabolism were increased after exercise intervention. The 30-second sit-up test and 3-minute walking were increased, and the 10-time sit-to-stand was decreased significantly. This may be related to increase of leg and abdominal muscular strength. The exercise intervention program increased salivary 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) activities significantly. These results suggested that 11β-HDS2 became the index for the increase of muscular strength to prevent LS. 展开更多
关键词 SALIVARY Cortisol SALIVARY CORTISONE 11β--hydroxysteroid Dehydrogenase Muscle Weight STRENGTH EXERCISE
暂未订购
Edema, Enigma: 11 B-Hydroxysteroid Dehydrogenase Type 2 Inhibition by Sweetener “Stevia”
8
作者 Salina Esmail Udaya M. Kabadi 《Open Journal of Endocrine and Metabolic Diseases》 2012年第3期49-52,共4页
Intrduction: Edema, Hypertension and Hypokalemia occur with inhibition of 11 B-Hydroxysteroid Dehydrogenase Type 2 (11B-HSD2) by chronic Licorice ingestion. However, a similar presentation following a chronic use of a... Intrduction: Edema, Hypertension and Hypokalemia occur with inhibition of 11 B-Hydroxysteroid Dehydrogenase Type 2 (11B-HSD2) by chronic Licorice ingestion. However, a similar presentation following a chronic use of another commonly used sweetener “Stevia” is not reported. Objective: To document a first case report of a subject presenting with Edema, Prehypertension and Hypokalemia induced by 11B-HSD2 inhibition induced by chronic ingestion of sweetener stevia. Case Report: 32 year old Caucasian woman presented with generalized edema (feet, hands and face) of over 6 months. She was noted to also manifest Prehypertension (138/88 mmHg) and Hypokalemia (3.4 mM/l). Laboratory tests revealed decline in serum aldosterone and plasma renin activity, an increase in plasma cortisol/cortisone ratio. On persistent interrogation, patient admitted to daily consumption of sweetener stevia for over 9 months. All the presenting manifestations resolved with normalization of the laboratory tests on withdrawal of stevia. Conclusion: This case report indicates that chronic ingestion of sweetener stevia may induce edema, hypertension and hypokalemia via reduced conversion of cortisol into cortisone by inhibition of 11 B-Hydroxysteroid Dehydrogenase Type 2. 展开更多
关键词 EDEMA ENIGMA 11 B-hydroxysteroid DEHYDROGENASE TYPE 2 SWEETENER “Stevia”
暂未订购
Expression of 11β-Hydroxysteroid Dehydrogenase mRNA in Rat Leydig Cells
9
作者 高惠宝 GERen-Shan MATTHEWP.Hardy 《Journal of Reproduction and Contraception》 CAS 1998年第1期34-40,共7页
11β-hydroxysteroid dehydrogenase (11β-HSD) in Leydig cells regulates sterodogenesis by controlling intra cellular glucocorticoid (corticosterone, B, in rat) concentration.Prior to the 26th postnatal day, 11β-HSD is... 11β-hydroxysteroid dehydrogenase (11β-HSD) in Leydig cells regulates sterodogenesis by controlling intra cellular glucocorticoid (corticosterone, B, in rat) concentration.Prior to the 26th postnatal day, 11β-HSD is absent from rat immature Leydig cells. Asthe Leydig cells are matured, the enzyme is gradually produced. The highest levels of11β-HSD activity are present in adult rat Leydig cells. 11β-HSD controls the intracellular glucocorticoid concentration in Leydig cells and the glucocorticoids at the physiologicallevels also regulate levels of 11β-HSD activity in Leydig cells. The expressions of 11βHSD mRNA in Leydig cells from three different age groups of rats and adrenalectomizedrats (ADX), with and without B replacement were Observed in this study. The steady statelevels of 11β-HSD mRNA could not be detected in Leydig cells from immature rats aged21 days, but this could be detected in those aged 45 days. The highest levels of expressionOf 11β-HSD mRNA were found in adult Leydig cells. The mRNA expression of 11β-HSD was declined in Leydig cells after adrenalectomy, and this decline was prevented byB replacement (the levels were restored to control). The results indicated that 11β-HSDmRNA leVels expressed in three different age groups of rats are parallel with those ofantigen by immunohistochemical analysis and with those of enzyme activity by biochemicalmeasurement in previous studies. Similarly, the effect of B at physiological and endogenous levels on the expressions Of 11β-HSD mRNA corresponded to that on enzyme activity. 展开更多
关键词 11β-hydroxysteroid dehydrogenasc Leydig cell EXPRESSION
全文增补中
功能性胆汁酸生物合成及应用研究进展 被引量:2
10
作者 郑苗 常超 +4 位作者 苏琪 蔡成岗 逯与运 赵敏洁 蔡海莺 《食品科学》 EI CAS 北大核心 2025年第1期255-265,共11页
胆汁酸(bile acid,BA)作为胆汁重要的两性固醇类物质,可通过与受体、肠道菌群的相互作用调节糖脂代谢及稳态、肠道微生态、肠道屏障、炎症、免疫系统和神经系统等生理功能,影响机体代谢和营养健康。本文综述主要新型功能性BA的合成通路... 胆汁酸(bile acid,BA)作为胆汁重要的两性固醇类物质,可通过与受体、肠道菌群的相互作用调节糖脂代谢及稳态、肠道微生态、肠道屏障、炎症、免疫系统和神经系统等生理功能,影响机体代谢和营养健康。本文综述主要新型功能性BA的合成通路,系统总结主要功能性BA的功能活性、化学合成和生物转化研究进展。此外,归纳新型BA(异脱氧胆酸、异石胆酸、异别脱氧胆酸、异别石胆酸)功能性研究,以及新型BA生物转化酶的微生物来源、催化性质及其应用于BA合成的潜力。展望功能性BA在食品和医药等领域的应用潜力,为新型功能性BA的合成转化及综合应用提供一定参考。 展开更多
关键词 胆汁酸 功能性 生物转化 羟基类固醇脱氢酶 应用
在线阅读 下载PDF
大黄素调控11β-HSD1诱导小鼠骨髓间充质干细胞成骨细胞分化改善骨质疏松症作用研究
11
作者 汤新乐 杨浩 +4 位作者 张裕祥 梁静 李敏 赛达儿·阿布都沙拉木 张丽娟 《药物评价研究》 北大核心 2025年第6期1449-1459,共11页
目的基于差异表达基因分析与实验验证探讨大黄素治疗骨质疏松症的作用机制。方法从基因表达综合数据库(GEO)中筛选骨质疏松症的芯片数据,经GEO2R软件处理获取差异基因(DEGs),结合文献分析选择11β-羟基类固醇脱氢酶1(11β-HSD1)作为核... 目的基于差异表达基因分析与实验验证探讨大黄素治疗骨质疏松症的作用机制。方法从基因表达综合数据库(GEO)中筛选骨质疏松症的芯片数据,经GEO2R软件处理获取差异基因(DEGs),结合文献分析选择11β-羟基类固醇脱氢酶1(11β-HSD1)作为核心基因进行研究;使用AutoDock软件分子对接模拟大黄素与11β-HSD1的结合活性;小鼠骨髓间充质干细胞(BMSCs)分别使用DMEM/F12培养基(对照组)、成骨分化专用培养基(成骨诱导组)、含不同浓度(2.5、5.0、10.0μmol∙L^(−1))大黄素的成骨分化专用培养基(大黄素组)进行培养,培养至14、21 d进行碱性磷酸酶(ALP)和茜素红染色观察判断成骨细胞分化成熟情况;培养至第7天时ELISA法检测细胞中ALP水平,实时荧光定量PCR(qRT-PCR)检测11β-HSD1与Runt相关转录因子2(Runx2)mRNA水平,Western blotting检测骨钙素(OCN)、骨桥蛋白(OPN)蛋白表达水平。结果从GEO数据库中获得44个与脂肪/成骨细胞分化相关的DEGs,在脂肪细胞分化组中RASD1、HSD11B1(又称11β-HSD1)、RGS2等31个基因表达量显著上调;SHRM、EGR1、TNS3等13个基因表达量显著下调。分子对接显示大黄素与11β-HSD1具有较好的结合活性。ALP/茜素红染色观察发现10μmol∙L^(−1)的大黄素组成骨细胞分化较多,与对照组差异明显。与成骨诱导组相比,大黄素可显著下调11β-HSD1 mRNA水平(P<0.01),显著上调ALP水平、Runx2 mRNA水平(P<0.01、0.001)。Western blotting检测结果显示,与成骨诱导组相比,大黄素组OCN蛋白表达显著升高(P<0.001),OPN蛋白表达呈升高趋势。结论大黄素体外诱导小鼠BMSCs成骨细胞分化,可能通过抑制11β-HSD1表达,增加Runx2表达发挥作用。 展开更多
关键词 大黄素 骨质疏松症 骨髓间充质干细胞(BMSCs) 成骨分化 11β羟基类固醇脱氢酶1(11β-HSD1) Runt相关转录因子2(Runx2)
原文传递
佛手柑内酯可能通过靶向HSD11B2抑制子痫前期进展
12
作者 陈婷婷 雷帝 +1 位作者 周晗璟 范翠芳 《武汉大学学报(医学版)》 2025年第8期963-969,共7页
目的:研究佛手柑内酯(Bg)在子痫前期(PE)中的治疗作用及可能作用靶点。方法:PE大鼠通过N-硝基-L-精氨酸甲酯(L-NAME)造模,给予Bg治疗后检测孕鼠血压、尿蛋白,以及仔鼠重量和头臀长等妊娠结局。通过RNA-seq分析不同组孕鼠胎盘基因表达差... 目的:研究佛手柑内酯(Bg)在子痫前期(PE)中的治疗作用及可能作用靶点。方法:PE大鼠通过N-硝基-L-精氨酸甲酯(L-NAME)造模,给予Bg治疗后检测孕鼠血压、尿蛋白,以及仔鼠重量和头臀长等妊娠结局。通过RNA-seq分析不同组孕鼠胎盘基因表达差异情况并找到可能作用靶点。通过公共数据验证作用靶点在PE和不同胎盘细胞中的表达。结果:Bg可以明显缓解PE大鼠的高血压及蛋白尿,并且对母胎没有明显毒性作用。通过RNA-seq和分子对接结果表明,羟基类固醇11-β脱氢酶2(HSD11B2)可能是Bg改善PE的作用靶点。HSD11B2在人类PE胎盘中表达下调,并且主要表达在绒毛滋养层细胞。Bg可以上调PE中HSD11B2的表达。结论:Bg可能通过靶向HSD11B2缓解PE发展,可能成为预防和治疗PE的潜在药物。 展开更多
关键词 子痫前期 佛手柑内酯 羟基类固醇11-β脱氢酶2
原文传递
Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolicassociated Fatty Liver Disease 被引量:2
13
作者 Wen-Yue Liu Mohammed Eslam +11 位作者 Kenneth I.Zheng Hong-Lei Ma Rafael S.Rios Min-Zhi Lv Gang Li Liang-Jie Tang Pei-Wu Zhu Xiao-Dong Wang Christopher D.Byrne Giovanni Targher Jacob George Ming-Hua Zheng 《Journal of Clinical and Translational Hepatology》 SCIE 2021年第2期194-202,共9页
Background and Aims:In Europeans,variants in the hydroxysteroid 17-beta dehydrogenase 13(HSD17B13)gene impact liver histology in metabolic-associated fatty liver disease(MAFLD).The impact of these variants in ethnic C... Background and Aims:In Europeans,variants in the hydroxysteroid 17-beta dehydrogenase 13(HSD17B13)gene impact liver histology in metabolic-associated fatty liver disease(MAFLD).The impact of these variants in ethnic Chinese is unknown.The aim of this study was to investigate the potential associations in Chinese patients.Methods:In total,427 Han Chinese with biopsy-confirmed MAFLD were enrolled.Two single nucleotide polymorphisms in HSD17B13 were genotyped:rs72613567 and rs6531975.Logistic regression was used to test the association between the single nucleotide polymorphisms and liver histology.Results:In our cohort,the minor allele TA of the rs72613567 variant was related to an increased risk of fibrosis[odds ratio(OR):2.93(1.20–7.17),p=0.019 for the additive model;OR:3.32(1.39–7.91),p=0.007 for the recessive model],representing an inverse association as compared to the results from European cohorts.In contrast,we observed a protective effect on fibrosis for the minor A allele carriers of the HSD17B13 rs6531975 variant[OR:0.48(0.24–0.98),p=0.043 for the additive model;OR:0.62(0.40–0.94),p=0.025 for the dominant model].HSD17B13 variants were only associated with fibrosis but no other histological features.Furthermore,HSD17B13 rs6531975 modulated the effect of PNPLA3 rs738409 on hepatic steatosis.Conclusions:HSD17B13 rs72613567 is a risk variant for fibrosis in a Han Chinese MAFLD population but with a different direction for allelic association to that seen in Europeans.These data exemplify the need for studying diverse populations in genetic studies in order to fine map genome-wide association studies signals. 展开更多
关键词 Metabolic-associated fatty liver disease(MAFLD) Nonalcoholic fatty liver disease(NAFLD) hydroxysteroid 17-beta dehydrogenase 13(HSD17B13) Single nucleotide polymorphism(SNP)
原文传递
IFN-γ对神经母细胞瘤细胞增殖的抑制作用及神经母细胞瘤组织中SULT2B1蛋白表达的临床意义
14
作者 杨映然 王靖 +5 位作者 仇友政 张杉杉 李娜 申伟 陈瑛 王宁 《吉林大学学报(医学版)》 北大核心 2025年第5期1267-1273,共7页
目的:探讨干扰素γ(IFN-γ)对神经母细胞瘤细胞增殖的影响和IFN-γ潜在的基因签名,以及该基因签名在神经母细胞瘤细胞中的表达及其与不良预后的关系,阐明IFN-γ及其基因签名在神经母细胞瘤中的作用。方法:选取神经母细胞瘤细胞SK-N-BE(... 目的:探讨干扰素γ(IFN-γ)对神经母细胞瘤细胞增殖的影响和IFN-γ潜在的基因签名,以及该基因签名在神经母细胞瘤细胞中的表达及其与不良预后的关系,阐明IFN-γ及其基因签名在神经母细胞瘤中的作用。方法:选取神经母细胞瘤细胞SK-N-BE(2)(原癌基因N-MYC扩增型)和SH-SY5Y(原癌基因N-MYC非扩增型)细胞,分别使用不同浓度(0、500、750、1000和1500μg·L^(-1))IFN-γ处理24 h后,采用细胞计数试剂盒8(CCK-8)法检测细胞增殖活性,并收集细胞样本进行转录组测序,确定IFN-γ基因签名。收集23例神经母细胞瘤组织和6例正常肾上腺组织,采用免疫组织化学法(IHC)检测IFN-γ基因签名的表达。根据IFN-γ基因签名表达水平将神经母细胞瘤组织分为SULT2B1低表达和高表达组,分析IFN-γ基因签名表达水平与患者不良预后的关系。结果:CCK-8法,随着IFN-γ浓度增加,SK-N-BE(2)细胞增殖活性明显降低(P<0.01),4组SK-N-BE(2)细胞抑制率分别为6.73%、6.77%、7.67%和9.19%;随着IFN-γ浓度升高,SH-SY5Y细胞增殖活性明显升高(P<0.01),4组SH-SY5Y细胞增殖率分别为46.80%、79.19%、70.30%和72.33%。转录组测序分析确定了IFN-γ的基因签名可能为羟基类固醇磺基转移酶2B1(SULT2B1)。IHC检测,神经母细胞瘤组织中SULT2B1蛋白表达量明显升高。临床资料分析,SULT2B1低表达组与高表达组患者年龄(Z=-2.618,P=0.018)、淋巴结转移(χ^(2)=4.439,P=0.035)和远处转移(χ^(2)=5.856,P=0.016)情况比较差异有统计学意义。结论:IFN-γ可以抑制SK-N-BE(2)细胞增殖,促进SH-SY5Y细胞增殖;IFN-γ的基因签名可能为SULT2B1;SULT2B1在神经母细胞瘤组织中表达上调,且SULT2B1高表达与神经母细胞瘤患者不良预后有关联。 展开更多
关键词 神经母细胞瘤 干扰素Γ 羟基类固醇磺基转移酶2B1 肿瘤基因 肿瘤转移
暂未订购
Transforming growth factor-β1 and epidermal growth factor decrease the expression of 17β-hydroxysteroid dehy-drogenase type 2 in endo-metrial carcinoma cells
15
作者 Xiaohong Li Zhijie Xiao Yunshang Piao 《Chinese Science Bulletin》 SCIE EI CAS 2002年第1期43-47,共5页
Estradiol (E2) is the major molecular form of estrogens. Its biological effects are determined by estrogen receptors and intracellular E2 concentration in target cells. Regulation of intracellular E2 concentration inv... Estradiol (E2) is the major molecular form of estrogens. Its biological effects are determined by estrogen receptors and intracellular E2 concentration in target cells. Regulation of intracellular E2 concentration involves the action of 17p-hydroxysteroid dehydrogenase (17HSD) type 2, the enzyme inactivating E2 to estrone. It has been demon-strated that 17HSD type 2 is expressed in normal endo-metrial epithelia and emdometrial carcinoma cells (RL 95-2). However, the regulatory mechanism of 17HSD type 2 expression in emdometrial cancer cells remains unknown. In the present study, the effects of transforming growth factor-β1 (TGF-β1) and epidermal growth factor (EGF) on 17HSD type 2 expression in RL 95-2 cells have been investigated using enzyme activity assay and Northern blot analysis. After stimulation with TGF-P1 or EGF, the in vivo oxidative 17HSD activity in RL 95-2 cells was significantly decreased. It appeared that the inhibitory effect of TGF-β1 and EGF onthe enzyme activity of 17HSD type 2 展开更多
关键词 emlometrium. ESTROGEN 17β-hydroxysteroid dehydro-genase GROWTH factor.
暂未订购
HSD17B4通过调控氧化应激诱导STAT1表达促进肝癌细胞侵袭迁移
16
作者 刘鹏月 孔令玉 +5 位作者 刘英 李志勇 张海芬 李刚 解建佳 路欣 《肿瘤学杂志》 2025年第6期498-507,共10页
[目的]探讨17β-羟基类固醇脱氢酶4(17β-hydroxysteroid dehydrogenase 4,HSD17B4)在肝细胞癌(hepatocellular carcinoma,HCC)恶性进展中的作用及其潜在的作用机制。[方法]采用免疫组织化学(immunohistochemistry,IHC)实验检测HCC患者... [目的]探讨17β-羟基类固醇脱氢酶4(17β-hydroxysteroid dehydrogenase 4,HSD17B4)在肝细胞癌(hepatocellular carcinoma,HCC)恶性进展中的作用及其潜在的作用机制。[方法]采用免疫组织化学(immunohistochemistry,IHC)实验检测HCC患者癌组织和癌旁组织中HSD17B4的表达水平;将HSD17B4的干扰RNA(siHSD17B4)和过表达质粒(pCMV6-HSD17B4)转染至Huh7和HepG2细胞中,进行HSD17B4敲降和过表达处理;采用细胞划痕实验和Transwell实验检测肝癌细胞的迁移和侵袭能力;采用蛋白免疫印迹(Western blot)实验检测波形蛋白(vimentin,VIM)和基质金属蛋白酶9(matrix metalloproteinase 9,MMP9)等促侵袭迁移蛋白的表达水平;采用Western blot实验和细胞免疫荧光技术分别检测HSD17B4对信号转导和转录激活因子1(signal transduction and activator of transcription 1,STAT1)表达的影响和对磷酸化STAT1(p-STAT1)核转位的影响;采用荧光探针和比色法分别检测细胞内的活性氧(reactive oxygen species,ROS)和丙二醛(malondialdehyde,MDA),以评估HSD17B4对肝癌细胞内氧化应激的影响。[结果]HSD17B4在HCC患者癌组织中的表达量高于癌旁组织(1.569±0.218 vs 1.000±0.139,t=4.92,P=0.001);HSD17B4过表达后,Huh7和HepG2细胞的迁移能力增强(t=6.60,P=0.003;t=5.54,P=0.005),侵袭能力增强(t=5.61,P=0.013;t=9.07,P<0.001);HSD17B4敲降后,Huh7和HepG2细胞的迁移能力降低(t=4.96,P=0.008;t=6.14,P=0.004),侵袭能力也降低(t=7.06,P=0.002;t=4.57,P=0.010)。HSD17B4过表达导致肝癌细胞VIM、MMP9和STAT1的表达水平均升高(P<0.05),细胞内ROS和MDA水平均降低(P<0.05);HSD17B4敲降后则出现相反的结果(P<0.05)。HSD17B4对p-STAT1核转位的影响不明显。[结论]HSD17B4可能通过制衡细胞内氧化应激水平调控STAT1的表达从而促进HCC细胞侵袭迁移。 展开更多
关键词 肝细胞癌 羟基类固醇脱氢酶 侵袭 迁移 氧化应激 信号转导和转录激活因子
原文传递
17β-HSD1在卵巢恶性上皮性肿瘤中的表达及临床意义 被引量:1
17
作者 赵奕涵 申颖 戴姝艳 《中国医科大学学报》 CAS 北大核心 2024年第11期1012-1016,1024,共6页
目的检测17β-羟类固醇脱氢酶1(17β-HSD1)在卵巢恶性上皮性肿瘤组织中的表达,分析其与病理特征和预后的关系。方法选取卵巢恶性、交界性、良性上皮性肿瘤患者各70例。采用免疫组织化学染色检测17β-HSD1的表达情况。比较3组患者间17β-... 目的检测17β-羟类固醇脱氢酶1(17β-HSD1)在卵巢恶性上皮性肿瘤组织中的表达,分析其与病理特征和预后的关系。方法选取卵巢恶性、交界性、良性上皮性肿瘤患者各70例。采用免疫组织化学染色检测17β-HSD1的表达情况。比较3组患者间17β-HSD1表达水平的差异,分析17β-HSD1表达水平与患者各项临床病理特征及预后的关系。结果17β-HSD1在卵巢恶性上皮性肿瘤组织中高表达,卵巢恶性上皮性肿瘤组织中17β-HSD1的表达水平与FIGO分期、淋巴结转移、糖类抗原125(CA125)和人附睾蛋白4(HE4)水平相关(P<0.05),而与患者的绝经情况、肿瘤分化程度、病理类型、腹水无明显相关(P>0.05)。17β-HSD1表达水平、术前CA125和HE4水平、肿瘤分化程度、FIGO分期是卵巢恶性上皮性肿瘤预后的影响因素。多因素Cox回归分析提示,17β-HSD1表达水平和FIGO分期是影响卵巢恶性上皮性肿瘤预后的独立危险因素。结论17β-HSD1在卵巢恶性上皮性肿瘤组织中高表达,与肿瘤的发生、发展密切相关,是影响患者总生存期的独立危险因素之一。 展开更多
关键词 雌激素 17β-羟类固醇脱氢酶1 卵巢恶性上皮性肿瘤 卵巢交界性上皮性肿瘤 卵巢良性上皮性肿瘤
暂未订购
洋地黄毒苷合成途径3β-羟基类固醇脱氢酶基因克隆及功能分析
18
作者 韩洋 夏梦 +2 位作者 张逸风 苏平 黄璐琦 《中国中药杂志》 CAS CSCD 北大核心 2024年第2期370-378,共9页
洋地黄毒苷作为中药洋地黄中重要的次生代谢产物,是临床中最常用的强心药物之一。3β-羟基类固醇脱氢酶(3βHSD)是洋地黄毒苷生物合成途径酶,属于短链脱氢酶/还原酶(SDR)家族,起到氧化和异构前体化合物甾醇的作用,参与强心苷类化合物的... 洋地黄毒苷作为中药洋地黄中重要的次生代谢产物,是临床中最常用的强心药物之一。3β-羟基类固醇脱氢酶(3βHSD)是洋地黄毒苷生物合成途径酶,属于短链脱氢酶/还原酶(SDR)家族,起到氧化和异构前体化合物甾醇的作用,参与强心苷类化合物的生物合成。该研究从洋地黄中首次克隆得到2个3βHSD基因,实验结果显示:Dp3βHSD1开放阅读框为780 bp,编码259个氨基酸;Dp3βHSD2开放阅读框为774 bp,编码257个氨基酸。Dp3βHSD1/2均具有TGxxxA/GxG辅因子结合位点和YxxxK催化位点基序,含有SDR酶的活性位点和NAD(P)结合位点。通过体外酶促试验证实Dp3βHSD1/2均能催化孕烯醇酮生成洋地黄毒苷前体化合物黄体酮,且Dp3βHSD1较Dp3βHSD2具有更强的催化能力。基因表达水平分析表明Dp3βHSD1基因在叶中的表达水平显著高于Dp3βHSD2,而洋地黄毒苷在叶中特异性富集,基于以上结果推测洋地黄毒苷生物合成途径中孕烯醇酮脱氢生成黄体酮过程主要由Dp3βHSD1催化完成。该研究成功解析了功能性3β-羟基类固醇脱氢酶,为进一步解析洋地黄中强心苷类化合物的生物合成途径奠定基础。 展开更多
关键词 洋地黄 洋地黄毒苷 3β-羟基类固醇脱氢酶 功能鉴定
原文传递
钩藤内生放线菌Streptomyces sp.IMW-B19化学成分研究
19
作者 郭永华 赵中振 +5 位作者 徐畅 刘莹 张媛 王贵阳 张薇 魏胜利 《中南药学》 CAS 2024年第6期1412-1417,共6页
目的 研究钩藤内生放线菌Streptomyces sp.IMW-B19发酵产物的次生代谢产物及部分化合物的生物活性。方法 该菌株的发酵产物采用ODS、Sephadex LH-20、半制备HPLC等色谱技术进行分离纯化,并采用ESI-MS和NMR鉴定化合物的化学结构。使用人... 目的 研究钩藤内生放线菌Streptomyces sp.IMW-B19发酵产物的次生代谢产物及部分化合物的生物活性。方法 该菌株的发酵产物采用ODS、Sephadex LH-20、半制备HPLC等色谱技术进行分离纯化,并采用ESI-MS和NMR鉴定化合物的化学结构。使用人肝癌HepG2细胞评价化合物1对11β-羟类固醇脱氢酶1活性的影响。结果 共分离得到11个化合物,经多种波谱数据分析和文献对比,分别鉴定为actiphenol(1)、苯甲酸薄荷酯A(2)、cyclo(L-Pro-L-Phe)(3)、胸苷(4)、11-hydroxy-4-amorphen-15-oic acid(5)、3-吲哚甲酸甲酯(6)、苯乙酸(7)、1-(3-ethylphenyl)-ethane-1,2-diol(8)、亚油酸(9)、亚油酸甲酯(10)和2-氨基-4-甲氧基苯甲酸(11)。化合物1对11β-羟类固醇脱氢酶1具有明显的抑制作用,在20 μmol·L^(-1)时,抑制率达到86.01%。结论 从钩藤内生放线菌Streptomyces sp.IMW-B19发酵产物中共分离得到11个化合物,其中化合物4、5、8为首次从链霉菌属的放线菌中分离得到。化合物1对11β-羟类固醇脱氢酶1具有明显的抑制作用。 展开更多
关键词 钩藤 内生放线菌 化学成分 次生代谢产物 11β-羟类固醇脱氢酶1
原文传递
甾醇脱氢酶的基因挖掘、分子改造及其催化合成熊去氧胆酸
20
作者 游智能 张仙 +1 位作者 李春秀 许建和 《上海医药》 CAS 2024年第7期16-23,共8页
本文介绍近年来利用以甾醇脱氢酶为核心元件的生物合成法制备熊去氧胆酸的研究进展,并提出了该技术进一步发展所面临的挑战和未来的研究方向,旨在为熊去氧胆酸的生物合成研究提供参考。
关键词 熊去氧胆酸 甾醇脱氢酶 生物合成
在线阅读 下载PDF
上一页 1 2 16 下一页 到第
使用帮助 返回顶部